Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS. - Wikidata - wikimedia - TriplyDB

Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS.

Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS.

http://www.wikidata.org/entity/Q37429911

about

Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies

P2860

Q57493682-75297007-0B2B-4FA7-8162-C3F1CDBDC008

P2860

Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS.

http://www.wikidata.org/entity/Q37429911

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clofarabine versus fludarabine ...... tation in adults with AML/MDS.

@en

Clofarabine versus fludarabine ...... tation in adults with AML/MDS.

@nl

type

label

Clofarabine versus fludarabine ...... tation in adults with AML/MDS.

@en

Clofarabine versus fludarabine ...... tation in adults with AML/MDS.

@nl

prefLabel

Clofarabine versus fludarabine ...... tation in adults with AML/MDS.

@en

Clofarabine versus fludarabine ...... tation in adults with AML/MDS.

@nl

P1433

Q37429911-0BA751E1-0AE8-40DF-A421-AA44185F1ACE

P1476

Q37429911-F349CE63-7393-4212-B00E-934E3D315F5A

P2093

Q37429911-0FF280EF-C75C-4BDB-A356-BA1D6CEAEFC3

Q37429911-15AB9A71-231A-4B7E-AA60-C0FE906F5000

Q37429911-16D6A219-BB9D-43B7-AEFD-158697A8DF58

Q37429911-17456644-0D8A-4C1A-9E3E-14C81B7FD16F

Q37429911-2B22435E-A667-4EE9-9DD1-9B11D6FCAE2B

Q37429911-31B5E017-F691-47F6-9287-688EADEC084E

Q37429911-4E509186-78AF-4F3D-A651-DB0A59FEE57D

Q37429911-640A0BEC-D21D-4784-A305-D57C79285919

Q37429911-702E37E8-5709-43F4-864B-316A822E4CB1

Q37429911-77DE6D28-AE44-4F63-8538-85A7C5787FAA

P2860

Q37429911-04380B2F-ED48-400B-9D35-A15B01577445

Q37429911-0B771C99-6361-4C79-8FB7-B6346CFE1E81

Q37429911-2EDC5D02-2C58-4871-A0E7-7953205C535F

Q37429911-36903522-95D3-46DC-B10F-E6EE935B914B

Q37429911-50DFAD5E-69EA-4786-9FDE-B17E260A0A6E

Q37429911-56835FB0-F1E0-4941-BDB8-D28D94F732C4

Q37429911-733AF1B1-C3BE-4AB6-A5FE-35C17C6D4AD9

Q37429911-7346E10E-A520-4B3B-B7E3-DE91BF2267D6

Q37429911-778F4230-2F24-4FC5-A087-A558BE171E40

Q37429911-7A9B8E0F-7948-42BE-8CA1-66360DBF921D

P304

Q37429911-BECEF7AF-D25E-4EFA-AA60-4FBB38787099

P31

Q37429911-7EF73838-FD7C-4166-A85B-0BCF149F8828

P356

Q37429911-97BCAA8D-8969-4208-B574-91824F02179D

P407

Q37429911-D3A1AB1E-0379-4DAE-A90E-6981CED24813

P433

Q37429911-C6AE2D42-65FC-4961-A7CC-258090EAB914

P478

Q37429911-AAF91079-7F32-40B1-AE16-D704E17B0782

P50

Q37429911-EF689D5E-D1F0-4701-8335-C3E399241AF5

P577

Q37429911-5DEC8D4A-B502-4498-9802-1820376AC90B

P698

Q37429911-6D9F845B-075C-4F12-88A3-E7CB7C110FF7

P932

Q37429911-FD458131-5529-459E-9732-EC7479546BBC

P356

P1433

Cancer Medicine

P1476

Clofarabine versus fludarabine ...... tation in adults with AML/MDS.

@en

P2093

Anne Huynh

http://www.w3.org/2001/XMLSchema#string

Bruno Lioure

http://www.w3.org/2001/XMLSchema#string

Claude-Eric Bulabois

http://www.w3.org/2001/XMLSchema#string

Didier Blaise

http://www.w3.org/2001/XMLSchema#string

Etienne Daguindau

http://www.w3.org/2001/XMLSchema#string

Faezeh Legrand

http://www.w3.org/2001/XMLSchema#string

Florence Beckerich

http://www.w3.org/2001/XMLSchema#string

Gaelle Guillerm

http://www.w3.org/2001/XMLSchema#string

Ibrahim Yakoub-Agha

http://www.w3.org/2001/XMLSchema#string

Jean-Henri Bourhis

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Myeloid Leukemia

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

The role of clofarabine in acute myeloid leukemia.

Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies

Revised international prognostic scoring system for myelodysplastic syndromes.

Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant

Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.

Biology of the bone marrow microenvironment and myelodysplastic syndromes.

P304

3068-3076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.880

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Jacques-Olivier Bay

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27748046

http://www.w3.org/2001/XMLSchema#string

P932

5119961

http://www.w3.org/2001/XMLSchema#string